or Try an Advanced Search...

    Technical Analysis for ADIL - Adial Pharmaceuticals, Inc

    Grade Last Price % Change Price Change
    F 1.59 3.25% 0.05
    ADIL closed up 3.25 percent on Wednesday, May 8, 2024, on 2 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 10
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ADIL trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 3.25%
    Down 3 Days in a Row Weakness 3.25%
    Oversold Stochastic Weakness 3.25%
    Wide Bands Range Expansion -2.45%
    Oversold Stochastic Weakness -2.45%
    Fell Below 50 DMA Bearish -6.47%
    MACD Bearish Centerline Cross Bearish -6.47%
    Older End-of-Day Signals for ADIL ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 22 hours ago
    Up 5% about 22 hours ago
    Up 3% about 22 hours ago
    Up 2% about 22 hours ago
    Up 1% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADIL Chart by TradingView
    Basic chart:

    Profile

    Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of a therapeutic agent for the treatment of alcohol use disorder (AUD). Its lead drug product is AD04. AD04 is a selective serotonin-3 antagonist. AD04 can also be used for the treatment of other addictive disorders, such as obesity, smoking, and drug addiction. The Company has completed a Phase-II clinical trials of AD04.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Alcohol Medication Mental Health Obesity Psychiatry Smoking Drug Products Addiction

    Is ADIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 22 Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
    Apr 22 EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent
    Apr 12 Adial Pharmaceuticals files to sell 2.37M common shares for holders
    Apr 12 Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
    Apr 11 Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today
    Apr 10 S&P 500 Down 1%; Delta Air Lines Posts Upbeat Earnings
    Apr 10 Adial stock rallies 81% on data for alcohol abuse drug
    Apr 10 Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
    Apr 2 Adial Pharmaceuticals reports FY results
    Apr 2 Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
    See more ADIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.0
    52 Week Low 0.765
    Average Volume 7,831,376
    200-Day Moving Average 2.38
    50-Day Moving Average 1.82
    20-Day Moving Average 1.93
    10-Day Moving Average 1.67
    Average True Range 0.26
    RSI (14) 45.36
    ADX 18.16
    +DI 22.82
    -DI 22.68
    Chandelier Exit (Long, 3 ATRs) 2.33
    Chandelier Exit (Short, 3 ATRs) 1.87
    Upper Bollinger Bands 2.69
    Lower Bollinger Band 1.18
    Percent B (%b) 0.27
    BandWidth 78.11
    MACD Line -0.04
    MACD Signal Line 0.01
    MACD Histogram -0.0431
    Fundamentals Value
    Market Cap 2.64 Million
    Num Shares 1.66 Million
    EPS -8.98
    Price-to-Earnings (P/E) Ratio -0.18
    Price-to-Sales 0.00
    Price-to-Book 0.82
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.78
    Resistance 3 (R3) 1.79 1.72 1.75
    Resistance 2 (R2) 1.72 1.67 1.72 1.74
    Resistance 1 (R1) 1.66 1.64 1.69 1.65 1.73
    Pivot Point 1.59 1.59 1.61 1.59 1.59
    Support 1 (S1) 1.53 1.54 1.56 1.53 1.45
    Support 2 (S2) 1.46 1.51 1.46 1.44
    Support 3 (S3) 1.40 1.46 1.43
    Support 4 (S4) 1.40